Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003:101:53-6; discussion 56-7.

Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments

Affiliations
Clinical Trial

Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments

Devron H Char et al. Trans Am Ophthalmol Soc. 2003.

Abstract

Purpose: To assess whether laser-induced hyperthermia in conjunction with proton irradiation of choroidal melanoma may more rapidly decrease exudative retinal detachments.

Design: Case-control study.

Methods: This was a single-center prospective phase 1 study of choroidal melanoma patients with exudative retinal detachments. These tumors did not overhang the optic disc, involve the fovea, or have greater than 40% involvement of the ciliary body. Patients were treated with laser-induced hyperthermia and proton radiation; results were compared with those of similar patients treated at the same institution with only proton radiation. Patients were followed up in an identical manner for loss of subretinal fluid, visual acuity change, and visual field alterations.

Results: All 11 patients treated with combined laser and proton therapy had resorption of subretinal fluid with a mean duration of retinal detachment of 193 days, compared with 263 days in the group treated with only proton therapy (P<.04). At 1 year, visual acuity was similar in both groups.

Conclusions: Combined laser-induced hyperthermia and proton radiation may dissipate exudative detachments more rapidly than radiation alone.

PubMed Disclaimer

Similar articles

References

    1. Trans Am Ophthalmol Soc. 1999;97:407-27; discussion 427-34 - PubMed
    1. Ophthalmology. 1998 Aug;105(8):1419-24 - PubMed
    1. Klin Oczna. 2000;102(4):249-52 - PubMed
    1. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2085-93 - PubMed
    1. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):138-47 - PubMed

Publication types